What are the causes of paresthesias associated with Semaglutide (Glucagon-like peptide-1 receptor agonist)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Semaglutide can sometimes cause paresthesias, and if you experience these symptoms, you should report them to your healthcare provider promptly, who may recommend continuing the medication with careful monitoring, adjusting the dose, or switching to an alternative GLP-1 receptor agonist like dulaglutide or liraglutide. The sensations most commonly affect the hands, feet, or face and may be temporary. According to the most recent study on semaglutide safety 1, the medication has an overall favorable risk/benefit profile for patients with type 2 diabetes, but it can induce mild-to-moderate and transient gastrointestinal disturbances and increases the risk of biliary disease.

Potential Causes and Management

  • Paresthesias could potentially be related to rapid weight loss causing vitamin deficiencies (particularly B vitamins), or might indicate rare neurological side effects.
  • Staying well-hydrated, ensuring adequate vitamin intake (especially B12, folate, and other B vitamins), and gradually increasing the semaglutide dose as prescribed may help minimize these symptoms.
  • The study on semaglutide safety 1 highlights the importance of careful monitoring, particularly for patients at risk for deterioration of existing diabetic retinopathy.

Alternative Options

  • If symptoms worsen or become intolerable, your provider might suggest switching to an alternative GLP-1 receptor agonist like dulaglutide or liraglutide.
  • The choice of alternative medication would depend on individual patient factors, including medical history, current medications, and specific needs.

Key Considerations

  • Semaglutide has been shown to be effective in improving glycemic control and causing weight loss, but potential safety concerns have arisen over the years 1.
  • The medication's safety profile is similar to that of other GLP-1RAs, with no unexpected safety issues arising to date 1.

References

Research

Safety of Semaglutide.

Frontiers in endocrinology, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.